May 18, 2018 / 9:45 PM / 6 months ago

BRIEF-Astrazeneca Says U.S. FDA Approved Lokelma In U.S. For Treatment Of Adults With Hyperkalaemia

May 18 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA SAYS U.S. FDA APPROVED LOKELMA IN THE U.S. FOR THE TREATMENT OF ADULTS WITH HYPERKALAEMIA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below